INOpulse®

COMBINATION_PRODUCT2 trials

Sponsors

Bellerophon Pulse Technologies, Bellerophon

Conditions

Pulmonary FibrosisPulmonary Hypertension

Phase 2

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

BellerophonPulmonary Fibrosis, Pulmonary Hypertension

Start: 2017-12-29End: 2023-12-31Updated: 2023-02-28

Phase 3

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

TerminatedNCT03267108

Bellerophon Pulse TechnologiesPulmonary Fibrosis, Pulmonary Hypertension

Start: 2020-12-14End: 2023-06-30Updated: 2023-07-27

Related Papers

Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial

Annals of the American Thoracic Society2024-08-143 citations